Bioreactor Systems in Bone Tissue Engineering

Bioreactor systems in bone tissue engineering are designed to emulate the physiological and mechanical environment of developing bone. Through controlled provision of nutrients, oxygen, biochemical factors and biophysical stimuli such as shear stress and compression, these systems facilitate the cultivation of three-dimensional cell–scaffold constructs of clinically relevant size and complexity. Common configurations include spinner flasks, rotating-wall vessels, perfusion flow reactors, compression chambers and emerging microfluidic platforms, each offering bespoke control over mass transfer and mechanical cues. By promoting uniform cell distribution, extracellular matrix deposition and mineralisation, bioreactors enhance osteogenic differentiation and support the generation of viable bone graft substitutes. Applications span from craniofacial reconstruction and critical-size defect repair to high-throughput screening models that recapitulate bone physiology. Advances in automation and modular design are driving scalable production, opening avenues for personalised graft fabrication and mechanistic studies of bone development and disease. The continued integration of real-time monitoring and computational modelling promises further refinement of culture parameters for improved clinical translation.

Research from Nature Portfolio

A prototype standalone perfusion–compression bioreactor combining medium flow with cyclic mechanical loading has demonstrated a marked improvement in cell viability and matrix mineralisation within chitosan–graphene scaffolds seeded with human bone marrow stem cells. The system applies daily dynamic compression alongside continuous perfusion, resulting in enhanced extracellular matrix deposition and uniform cell distribution throughout the scaffold core. These findings underscore the importance of coordinated mechanical and biochemical stimulation in steering osteogenic commitment and pave the way for multifunctional devices that can investigate stem cell mechanobiology while producing preconditioned grafts ready for in vivo implantation.

Research from all publishers

Recent developments in craniofacial tissue engineering have employed both in vitro and in vivo bioreactors to generate custom-shaped bone grafts without donor-site morbidity. In vitro perfusion chambers support patient-derived cells on porous scaffolds under dynamic flow, yielding large, mineralised constructs, while in vivo bioreactor strategies utilise implantation adjacent to vascularised tissues to mature mineralised grafts for subsequent transfer to defect sites. A microfluidic bone-on-a-chip platform has advanced 3D cell culture by integrating perfusion and biomechanical stimulation, enhancing osteoblast differentiation, mineralisation and viability within spheroid arrays, thereby offering a versatile tool for drug screening and disease modelling. Additionally, mechanobiological studies have shown that fluid shear in a perfusion bioreactor induces Rho–ROCK-mediated cytoskeletal contractility in bone marrow stromal cells, upregulating focal adhesion formation and osteogenic gene expression even in the absence of chemical supplements. Inhibition of contractile pathways abrogates these effects, demonstrating the central role of actomyosin mechanics in dynamic culture systems and informing the design of mechanically tuned bioreactors for bone regeneration.

Bioreactor Systems in Bone Tissue Engineering publication trend

The graph below shows the total number of articles in bioreactor systems in bone tissue engineering across all publications each year (not limited to Nature Index journals).

Technical terms

Perfusion bioreactor: A device that pumps culture medium through a scaffold to enhance nutrient and oxygen delivery while removing waste products.

Shear stress: The tangential force per unit area exerted by fluid flow, which influences cell morphology, signalling and differentiation.

Osteogenic differentiation: The process by which progenitor cells acquire the bone-forming phenotype, characterised by matrix production and mineral deposition.

Scaffold: A three-dimensional biomaterial structure that provides mechanical support and a template for cell attachment and tissue formation.

Cyclic compression: The application of time-varying mechanical load, mimicking physiological pressures to stimulate matrix synthesis and tissue maturation.

References

1. Bioreactor Systems for Human Bone Tissue Engineering. Processes (2014).
2. A standalone bioreactor system to deliver compressive load under perfusion flow to hBMSC-seeded 3D chitosan-graphene templates. Scientific Reports (2019).
3. Advances in In Vitro and In Vivo Bioreactor-Based Bone Generation for Craniofacial Tissue Engineering. BME Frontiers (2023).
4. Microfluidic device for enhancement and analysis of osteoblast differentiation in three-dimensional cell cultures. Journal of Biological Engineering (2023).
5. Unique osteogenic profile of bone marrow stem cells stimulated in perfusion bioreactor is Rho‐ROCK‐mediated contractility dependent. Bioengineering & Translational Medicine (2023).